I agree that this site is using cookies. You can find further informations here.
X
Baguley, B.
188  results:
Search for persons X
?
1

Comparison of the glim, espen and icd-10 criteria to diagno..:

Poulter, S. ; Steer, B. ; Baguley, B...
Clinical Nutrition ESPEN.  46 (2021)  - p. S569 , 2021
Link: https://doi.org/10.1016/..
 
?
2

Development and validation of a liquid chromatography–mass ..:

LUKKA, P ; KESTELL, P ; PAXTON, J.
Journal of Chromatography B.  875 (2008)  2 - p. 368-372 , 2008
Link: https://doi.org/10.1016/..
 
?
3

Modelling the flow of cytometric data obtained from unpertu..:

BASSE, B ; BAGULEY, B ; MARSHALL, E..
Bulletin of Mathematical Biology.  67 (2005)  4 - p. 815-830 , 2005
Link: https://doi.org/10.1016/..
 
?
4

Erratum to "Modelling the flow cytometric data obtained fro..:

BASSE, B ; BAGULEY, B ; MARSHALL, E..
Bulletin of Mathematical Biology.  67 (2005)  5 - p. 1153-1153 , 2005
Link: https://doi.org/10.1016/..
 
?
5

138 Enhancement of the action of the antivascular drug 5,6-..:

Baguley, B. ; Wang, L.Cs. ; Ching, L.-M....
European Journal of Cancer Supplements.  2 (2004)  8 - p. 44-45 , 2004
Link: https://doi.org/10.1016/..
 
?
6

149 Inhibition of vasculogenic mimicry in melanoma by the a..:

Zhao, L. ; Edgar, S. ; Marshall, E...
European Journal of Cancer Supplements.  2 (2004)  8 - p. 47-48 , 2004
Link: https://doi.org/10.1016/..
 
?
7

Analysis of radiation‐induced changes to human melanoma cul..:

Basse, B. ; Joseph, W. R. ; Marshall, E. S..
Cell Proliferation.  43 (2010)  2 - p. 139-146 , 2010
Link: https://doi.org/10.1111/..
 
?
8

Automated extraction of direct, reactive, and vat dyes from..:

Dockery, C. R. ; Stefan, A. R. ; Nieuwland, A. A....
Analytical and Bioanalytical Chemistry.  394 (2009)  8 - p. 2095-2103 , 2009
Link: https://doi.org/10.1007/..
 
?
9

96 POSTER Potential importance of the ceramide pathway in t..:

Baguley, B.C. ; Ding, Q. ; Kestell, P..
European Journal of Cancer Supplements.  6 (2008)  12 - p. 32-33 , 2008
Link: https://doi.org/10.1016/..
 
?
10

Pharmacokinetics of 5,6-dimethylxanthenone-4-acetic acid (A..:

Jameson, M. B. ; Baguley, B. C. ; Kestell, P....
Cancer Chemotherapy and Pharmacology.  59 (2006)  5 - p. 681-687 , 2006
Link: https://doi.org/10.1007/..
 
?
11

In vitro modelling of human tumour behaviour in drug discov..:

Baguley, B.C. ; Marshall, E.S.
European Journal of Cancer.  40 (2004)  6 - p. 794-801 , 2004
Link: https://doi.org/10.1016/..
 
?
12

NF-kappa B activation in vivo in both host and tumour cells..:

Woon, S.-T ; Zwain, S ; Schooltink, M.A...
European Journal of Cancer.  39 (2003)  8 - p. 1176-1183 , 2003
Link: https://doi.org/10.1016/..
 
?
13

A phase I trial of amsalog (CI-921) administered by intrave..:

Fyfe, D. ; Price, C. ; Langley, R.E....
Cancer Chemotherapy and Pharmacology.  47 (2001)  4 - p. 333-337 , 2001
Link: https://doi.org/10.1007/..
 
?
14

Analysis of the TGF β functional pathway in epithelial ovar..:

Francis-Thickpenny, K M ; Richardson, D M ; Ee, C C van...
British Journal of Cancer.  85 (2001)  5 - p. 687-691 , 2001
Link: https://doi.org/10.1054/..
 
?
15

The antitumour agent 5,6-dimethylxanthenone-4-acetic acid a..:

Philpott, M. ; Ching, L.-M. ; Baguley, B.C.
European Journal of Cancer.  37 (2001)  15 - p. 1930-1937 , 2001
Link: https://doi.org/10.1016/..
 
1-15